COMMON STOCK PURCHASE WARRANT VEDANTRA PHARMACEUTICALS, INC.Elicio Therapeutics, Inc. • July 13th, 2021 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the ten (10) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Vedantra Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [ ] shares (the “Warrant Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”).
COMMON STOCK PURCHASE WARRANT ELICIO THERAPEUTICS, INC.Elicio Therapeutics, Inc. • July 13th, 2021 • Pharmaceutical preparations • Delaware
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the ten (10) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Elicio Therapeutics, Inc., a Delaware corporation (f/k/a Vedantra Pharmaceuticals, Inc.) (the “Company”), up to [ ] shares (the “Warrant Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”).
